top of page
AR.jpg

IN THE STATES

ARKANSAS

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Arkansas in 2022.

AR

Economic
Output

$4.8B

Direct Jobs Supported by the Industry

2,838

Total Jobs Supported

16,179

State Total Vendor Relationships

76

State Total Vendor Spending

$3,797,089

Clinical
Trials

382

Investments at Clinical Trial Sites

$109M

Clinical Trial Participants

6,386

Total Economic Impact of Clinical Trial Sites

$265M

bottom of page